Aclarion to Present at LD Micro Main Event
Aclarion CEO Brent Ness will showcase the Nociscan platform at the upcoming conference in Los Angeles.
Updated on Oct. 13, 2026 in Industry — General
Live Poll
Do you generally trust presentations made by small-cap companies at investor conferences?
On October 20, 2026, Broomfield-based Aclarion will present its Nociscan diagnostic platform at the 20th Annual LD Micro Main Event. The conference brings together more than 100 public companies to connect with the investment community.
Why it matters
Presentations at high-profile investor conferences allow emerging growth companies to increase visibility among market stakeholders. This platform provides Aclarion the opportunity to communicate its operational goals, including an interim data readout expected later in 2026.
The 20th annual conference features more than 100 public companies presenting to an audience of investors. Aclarion maintains a cash runway that currently extends into the second half of 2027.
The players
Aclarion
This Colorado-based firm develops software solutions for the medical diagnostics market.
Brent Ness
He serves as the Chief Executive Officer of Aclarion.
LD Micro
Founded in 2006, this organization is a subsidiary of Freedom US Markets focused on small-cap investor relations.
The details
Aclarion CEO Brent Ness is scheduled to speak at 11:30 AM PT, highlighting the company's Nociscan SaaS platform designed for the diagnosis of low back pain. The company is among the many entities participating in the event held at the Luxe Sunset Boulevard Hotel.
Timeline
October 19, 2026: Registration for the LD Micro Main Event begins.
October 20, 2026: Aclarion CEO Brent Ness presents at 11:30 AM PT.
October 21, 2026: The 20th Annual LD Micro Main Event concludes.
Market Landscape
Aclarion's participation follows the historical pattern of the LD Micro Main Event in connecting emerging growth companies with institutional capital. This positioning allows Aclarion to compete for investor attention against more than 100 other public companies in the sector.
While the presentation primarily targets potential investors, the event helps secure the financial runway necessary for the continued development of Aclarion's Nociscan diagnostic tools. Interested parties can monitor the company's progress as it works toward an interim data readout later this year.
The takeaway
Investor conferences serve as vital venues for small-cap companies to explain their technological value to the market. Attendees should watch for the anticipated interim data readout to better understand the company's long-term performance trajectory.
Further reading
For broader trends in the current investment climate, visit the Industry — General section.
More information
To register for the conference, visit the LD Micro Main Event registration page.
Live Poll
Do you generally trust presentations made by small-cap companies at investor conferences?
